看通集團(01059.HK)擬折讓約9.95%配售6250.5萬股 淨籌1050萬港元
格隆匯1月21日丨看通集團(01059.HK)公吿,於2025年1月21日,公司與配售代理訂立配售協議,據此,配售代理已同意,根據配售協議所載條款及在其條件規限下,盡力按配售價每股配售股份0.172港元向不少於六名承配人配售62,505,000股配售股份。
配售價較股份於2025年1月21日(即配售協議日期)在聯交所所報收市價每股0.191港元折讓約9.95%;公司將收取所得款項淨額(經扣除配售佣金以及其他費用及開支後)將約為1050萬港元。公司擬將所得款項淨額用作集團一般營運資金以及收購位於香港的工業物業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.